AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Oramed Pharmaceuticals Inc.

ILA 1311.00 +$404.10 (+44.56%)
TLV · 30 Oct 2026 11:44 UTC
Previous Close
ILA 1310.00
Day Range
ILA 1310.00ILA 1350.00
Year Range
ILA 7.00ILA 1742.00
Market Cap
545.34M
AVG Volume
6.25K
Trailing/Forward PE
0.97/-
PEG ratio
-0
Dividend Yield
6.08%
Next Earnings Date
2026-11-12
Primary Exchange
Tel Aviv Stock ExchangeIL
Revenue (USD) · TTM
01M2M3M22 Q222 Q322 Q423 Q123 Q223 Q325 Q325 Q426 Q126 Q2
ORMP.TA Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q20
26 Q10
25 Q42M
25 Q32M
23 Q32.02M
23 Q22.7M
23 Q12.7M
22 Q42.7M
22 Q32.7M
22 Q22.7M
Net Income (USD) · TTM
-100M0100M200M22 Q222 Q322 Q423 Q123 Q223 Q325 Q325 Q426 Q126 Q2
ORMP.TA Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2174.51M
26 Q1110.24M
25 Q464.05M
25 Q343.85M
23 Q3-14.76M
23 Q2-18.79M
23 Q1-28.13M
22 Q4-36.75M
22 Q3-36.1M
22 Q2-35.7M
Operating Income (USD) · TTM
-60M-40M-20M022 Q222 Q322 Q423 Q123 Q223 Q325 Q325 Q426 Q126 Q2
ORMP.TA Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-14.53M
26 Q1-14.27M
25 Q4-15.09M
25 Q3-13.01M
23 Q3-21.63M
23 Q2-26.93M
23 Q1-34.55M
22 Q4-40.6M
22 Q3-38.92M
22 Q2-38.14M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ORMP.TA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

Oramed Pharmaceuticals Inc.
ORMP.TA
Stockpicker

Video analysis: ORMP.TA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ORMP.TA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.